Gregory T. Went, Chief Executive Officer, 10% Owner at Adamas Pharmaceuticals Inc (ADMS), sold 3,300 shares at $18.01 ($59K) on 2015-04-23, disclosed to the SEC on 2015-04-27.
Scheduled sale ($59k) by Chief Executive Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 900 | $16K | 27.3% |
| 2 | $18.01 | 2,400 | $43K | 72.7% |
| Total | $18.01 avg | 3,300 | $59K | 100% |
| Filing → |
| ADMS | SELL | 2018-03-22 | $234K | — | Filing → |
| ADMS | SELL | 2017-03-22 | $48K | — | Filing → |
| ADMS | SELL | 2015-05-14 | $49K | — | Filing → |